文献速递系统性红斑狼疮血管炎

系统性红斑狼疮中高密度脂蛋白功能研究解读

High-density lipoprotein functionality in systemic lupus erythematosus.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-25

本文综述系统性红斑狼疮(SLE)患者高密度脂蛋白(HDL)功能异常的机制。SLE以过度炎症和自身抗体为特征,患者早发动脉粥样硬化且死亡率高,传统血脂危险因素不能完全解释心血管风险增加。炎症通过改变HDL结构和功能参与心血管并发症,综述旨在识别SLE中HDL功能障碍的相关机制。

要点

  • SLE患者早发动脉粥样硬化且死亡率高,传统血脂危险因素不能完全解释心血管风险增加。
  • 自身抗体和循环免疫复合物可能通过损伤内皮、诱导促炎促黏附表型及改变脂蛋白代谢促进动脉粥样硬化。
  • 炎症可改变HDL结构导致功能异常,机制涉及apoA-I产生减少、LCAT活性降低及SAA、内皮脂肪酶、PLA2活性增加。

核心结论

  • SLE中炎症相关的HDL结构和功能改变可能参与心血管并发症的发生。

研究设计与样本

  • 本文为综述,旨在识别SLE患者HDL功能障碍的相关机制。

主要发现

  • SLE以过度炎症、自身抗体、巨噬细胞和补体激活及免疫介导组织损伤为特征。
  • SLE患者尽管治疗改善,仍出现早发动脉粥样硬化且死亡率高。
  • 高水平的致动脉粥样硬化脂蛋白(如LDL和VLDL)和低水平的HDL-C是SLE患者动脉粥样硬化心血管并发症的重要危险因素,但传统危险因素不能完全解释心血管疾病风险增加。
  • 炎症降低HDL水平的确切机制尚未明确,但apoA-I产生减少、LCAT活性降低以及SAA、内皮脂肪酶和PLA2活性增加均可能参与。
  • 炎症期间HDL结构发生多种改变,导致HDL功能改变,可能与SLE的心血管并发症相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic lupus erythematosus (SLE) is a heterogeneous disease which is characterized with excessive inflammation and autoantibodies, macrophage and complement activation, and subsequently immunologically mediated tissue damage. In spite of improved treatments of SLE, these patients experience premature atherosclerosis and the rate of mortality among them remains high. Autoantibodies and circulating immune complexes might contribute to the pathogenesis of atherosclerosis by injuring the endothelium, as well as inducing pro-inflammatory and pro-adhesive endothelial cell phenotypes, as well as altering the metabolism of lipoproteins involved in atherogenesis. Hence, high levels of atherogenic lipoproteins (like low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL)) and low levels of high-density lipoprotein (HDL-C) are important risk factors for atherosclerotic cardiovascular complications in SLE patients but these traditional risk factors fail to fully explain the increased risk of cardiovascular disease (CVD) in these patients. The exact mechanism by which inflammation decreases HDL levels is not defined, but decreases in apoA-I production and lecithin cholesterol acyltransferase (LCAT) activity, as well as increased serum amyloid A (SAA), endothelial lipase and secretory phospholipase A2 activity (PLA2) could all contribute. In addition, during inflammation multiple changes in HDL structure occur, leading to alterations in HDL function which may be implicated in the CVD complications of SLE. Therefore, this review will aim to identify the mechanisms implicated in HDL dysfunction which occurs in SLE patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Ganjali S, Shirmohammadi L, Read MI, et al. High-density lipoprotein functionality in systemic lupus erythematosus. Semin Arthritis Rheum. 2020. PMID: 32531506. doi:10.1016/j.semarthrit.2020.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。